It was reported to boston scientific corporation that a spaceoar vue device was implanted during spaceoar vue placement procedure on (b)(6) 2023.After the procedure, the patient developed shortness of breath and urticaria.The patient was sent to the emergency room and admitted overnight, where was treated with steroids and antihistamine.The patient's symptoms of shortness of breath improved, but the urticaria continued for approximately one day.No further information has been obtained despite good faith effort.
|